Tying in with the concentration of ACY-1215 used, our findings are in line with another study, whereby it was reported that treatment of melanoma and clear cell sarcoma cells with different pan-HDAC inhibitors resulted in reduced MITF expression in vitro and in vivo in a mouse melanoma xenograft model [59]. Here, MITF is linked to clear cell sarcoma.